Fedha

Beta
Hisa unazofuatilia
Sekta za hisa
Alama
Alama
Bei
Tofauti
Tofauti ya asilimia
Mwenendo wa data
Bei ya Awali
Fungua
Juu
Chini
Kiasi cha mauzo ya hisa
Mtaji wa Soko
SIXB
Materials
SIXB
Materials
SIXB
-0.21%
1,091.51
-2.30
-0.21%
—1,093.811,096.521,100.221,091.51——
SIXC
Communications
SIXC
Communications
SIXC
+0.22%
610.11
+1.34
+0.22%
—608.77608.77612.97608.77——
SIXE
Energy
SIXE
Energy
SIXE
-1.34%
1,237.98
-16.83
-1.34%
—1,254.811,253.011,253.871,226.33——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.93%
1,744.71
-16.40
-0.93%
—1,761.111,764.271,766.881,744.71——
SIXM
Financials
SIXM
Financials
SIXM
-0.37%
640.18
-2.40
-0.37%
—642.58644.87648.48640.18——
SIXR
Staples
SIXR
Staples
SIXR
-0.18%
849.58
-1.55
-0.18%
—851.13855.66858.75845.56——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.23%
217.48
-0.50
-0.23%
—217.98217.98218.65216.88——
SIXT
Technology
SIXT
Technology
SIXT
+1.52%
3,260.69
+48.86
+1.52%
—3,211.833,227.213,268.383,226.55——
SIXU
Utilities
SIXU
Utilities
SIXU
-0.69%
942.45
-6.53
-0.69%
—948.98948.58957.83941.97——
SIXV
Health care
SIXV
Health care
SIXV
-0.52%
1,466.80
-7.72
-0.52%
—1,474.521,479.031,481.041,466.80——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.22%
2,397.50
+5.38
+0.22%
—2,392.122,396.952,421.222,382.32——
Mapato ya Q1 2026 • imetolewa • Imepitisha kiasi cha mapato kwa hisa +8.04% • Kiasi kilichotarajiwa cha mapato kimezidi +0.55%
Angalia matokeo
AMGN:NASDAQ
Amgen Inc
US$ 329.82
-4.75%
(-16.43) Siku 1
US$ 329.57
-0.08% (-0.25)
Baada ya saa
Imefungwa: 1 Mei, 16:00:01 GMT -4  ·   USD
Alama zote
AlamaBeiTofautiTofauti ya asilimia
Inatayarisha maarifa maarufu ya AMGN...
Fungua
US$ 332.52
Juu
US$ 337.00
Chini
US$ 324.63
Mtaji wa soko
178.00B
Wastani wa kiasi cha mauzo
2.60M
Kiasi cha mauzo ya hisa
3.82M
Gawio
3.06%
Mgawo wa faida wa kila robo mwaka
US$ 2.52
Tarehe ya kutojumuisha gawio
15 Mei 2026
Uwiano wa bei ya hisa na mapato kwa kila hisa
23.18
Juu kwa wiki 52
US$ 391.29
Chini kwa wiki 52
US$ 261.43
EPS
US$ 14.23
Beta
0.47
Hisa za wawekezaji
539.69M
Idadi ya wafanyakazi
elfu 32
Habari
Kutoka kwenye vyanzo vya wavuti
Wasifu
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. The company is ranked 18th on the list of largest biomedical companies by revenue. The name "AMGen" is a portmanteau of the company's original name, Applied Molecular Genetics. The company's major products are Prolia and XGEVA for treatment of osteoporosis and bone diseases, Enbrel for treatment of autoimmune diseases, Repatha for treatment of hyperlipidemia, Otezla for treatment of psoriasis and psoriatic arthritis, Tepezza to treat Graves' ophthalmopathy, Evenity to treat osteoporosis, Kyprolis to treat cancer, Nplate to regulate platelet production, and Aranesp to stimulate erythropoiesis. Amgen has 17 clinical programs underway in Phase III, eight in Phase II, and 19 in Phase I. Its pipeline includes MariTide, an anti-obesity medication administered once per month by injection. The company receives approximately 80% of its revenues from sales to the three large U.S. drug wholesalers: McKesson Corporation, Cencora, and Cardinal Health. The company is ranked 134th on the Fortune 500 and 202nd on the Forbes Global 2000. Wikipedia
Kuhusu Amgen Inc
Afisa Mkuu Mtendaji (CEO)Robert A. Bradway
Wafanyakazielfu 31.5
Lilianzishwa8 Apr 1980
Makao makuuThousand Oaks, California, Marekani
Sekta-
Tovutiamgen.com
Ripoti ya mwisho
30 Apr 2026
Kipindi cha Kifedha
Robo1 2026
Mapato Yaliyosawazishwa kwa Kila Hisa au Kadirio
5.15/ (4.77 inakadiriwa)USD
+8.04%umepitiliza
Mapato au Kadirio
8.62B/ (8.57B inakadiriwa)USD
+0.55%umepitiliza
Mkutano pepe wa kujadili mapato ya robo ya Robo ya 1 ya mwaka wa fedha wa 2026
Inasubiri mkutano pepe wa kujadili mapato
Kwa muhtasariMaarifa kutoka kwenye ripoti na habari za hivi punde
Ripoti za awaliThamani zote katika USD
Loading Previous Earnings...
Taarifa ya mapato
Mapato
Mapato halisi
Thamani zote katika USD
Jun 2025
Sep 2025
Des 2025
Mac 2026
Mapato
9.18B
9.56B
9.87B
8.62B
Gharama ya bidhaa zilizouzwa
2.67B
2.74B
2.68B
2.74B
Gharama ya mapato
2.67B
2.74B
2.68B
2.74B
Gharama za utafiti na maendeleo
1.74B
1.90B
2.14B
1.72B
Jumla ya gharama za utafiti na maendeleo
-
-
-
-
Gharama za uuzaji, za jumla na za usimamizi
1.69B
1.72B
1.95B
1.60B
Gharama ya uendeshaji
3.50B
3.55B
4.18B
3.21B
Jumla ya gharama za uendeshaji
6.18B
6.29B
6.85B
5.91B
Mapato ya uendeshaji
3.00B
3.26B
3.01B
2.70B
Mapato mengine yasiyo ya uendeshaji
-113.00M
181.00M
143.00M
75.00M
EBT ikijumuisha vipengee visivyo vya kawaida
1.57B
3.92B
1.51B
2.08B
EBT bila kujumuisha vipengee visivyo vya kawaida
2.37B
2.72B
2.51B
2.08B
Gharama ya kodi ya mapato
136.00M
705.00M
181.00M
265.00M
Kiwango cha kodi kinachotumika
8.67%
17.98%
11.96%
12.72%
Gharama nyingine za uendeshaji
68.00M
-71.00M
82.00M
-133.00M
Mapato halisi
1.43B
3.22B
1.33B
1.82B
Kiwango cha faida halisi
15.60%
33.65%
13.51%
21.11%
Mapato kwa kila hisa
6.02
5.64
5.29
5.15
Mapato ya riba na uwekezaji
-
-
408.00M
-
Gharama ya riba
-694.00M
-685.00M
-1.06B
-657.00M
Jumla ya gharama halisi za riba
-694.00M
-685.00M
-653.00M
-657.00M
Gharama za kushuka kwa thamani na za kulipa deni
-
-
-
-
Mapato ya kampuni kabla ya riba, kodi, kushuka thamani na kulipa madeni
4.34B
4.57B
4.02B
3.97B
Faida au hasara kutokana na uuzaji wa vipengee
-
-
-
-
Maudhui yaliyotayarishwa kwa AI yanaweza kuwa na makosa. Pata maelezo zaidi
UsaidiziTuma maoniFaraghaSheria na MashartiKanusho

Utafiti

Majukumu yangu
Bado hujaanzisha jukumu lolote
Majukumu yako yataonekana hapa. Ratibu majukumu na uruhusu Google Finance ifanye kazi ukiwa mbali.
Violezo
Muhtasari wa hisa unazofuatilia
Uchanganuzi wa kila siku wa kabla ya soko kufunguliwa wa orodha ya hisa unazofuatilia
Mapato Yajayo
Ripoti za mapato yajayo katika wiki
Mabadiliko ya Bei na Kiasi cha Hisa Kisicho cha Kawaida
Onyo la mapema kuhusu mabadiliko ya kiwango cha miamala leo
Maudhui yaliyotayarishwa kwa AI yanaweza kuwa na makosa. Pata maelezo zaidi
UsaidiziTuma maoniFaraghaSheria na MashartiKanusho